Home Active Agrochemical IngredientAgrochemicals Three exposures to spike protein allow people to develop broad antibody immunity – also against Omicron

Three exposures to spike protein allow people to develop broad antibody immunity – also against Omicron

by admin
0 comment
 Omnicron, Covid, Research , SARS COV2  , Disorder, Pharmanews ,  Biopharmaceutical,  Company

Summary :

Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total of three exposures to the viral spike protein.

Since the beginning of the COVID-19 pandemic, SARS-CoV-2 has continued to evolve, with new variants of concern (VoCs) spreading rapidly. Highly contagious and partially capable of evading the immune response, Omicron has become the dominant variant in most countries.

Answers to the question how the immune systems can be “educated” to battle Omicron and other immune escape variants of the virus are provided by a team led by Professor Ulrike Protzer (Institute of Virology at Technical University of Munich and Helmholtz Munich), Professor Percy Knolle (University Hospital rechts der Isar of the Technical University of Munich), and Professor Oliver T. Keppler (Max von Pettenkofer Institute and Gene Center Munich at LMU). As they report in Nature Medicine, a total of three exposures to the viral spike protein leads to production of virus neutralizing antibodies not only in high quantity, but also high quality. These high-quality antibodies bind to the viral spike protein more vigorously and are also capable of effectively fighting the Omicron variant. This applies to triple-vaccinated people, to people who have recovered from COVID-19 and then had two vaccinations, and to double-vaccinated people who then had a breakthrough infection.

 Omnicron, Covid, Research , SARS COV2  , Disorder, Pharmanews ,  Biopharmaceutical,  Company


Longitudinal study with 171 participants

Since the beginning of the pandemic, voluntary participants from the staff at the University Hospital rechts der Isar at risk of infection participated in the study and were regularly tested. The researchers identified individuals who had contracted SARS-CoV-2 during the first wave of the pandemic in spring 2020, and compared them to a second group of people who had not been infected. Subsequently, both groups were offered vaccination with the mRNA-based COVID-19 vaccine from BioNTech/Pfizer and were monitored for almost two years. The cohort comprised 98 recovered persons and 73 persons without prior infection.

“This longitudinal study is particularly exciting, because we can follow how the immune response evolves over time against the virus and after vaccination” says Professor Knolle, pointing to a study by the team, which has just appeared in Nature Communications. In the new study the team now defined several parameters in the blood of study participants: the concentration of antibodies to the viral spike protein, the binding strength of these antibodies, and their ability to neutralize infection of SARS-CoV-2 variants in cell culture. For estimating the extent of protective immunity, the latter two parameters are particularly important. The study revealed that the ability of the immune system to neutralize the virus correlates only weakly with the antibody titer. Rather, it was critical how effectively these antibodies bind to the virus and thus disable infection.

As predicted from its many mutations, Omicron exhibited the most pronounced evasion from neutralizing antibodies compared to all other viral variants tested. “For Omicron, you need considerably more and better antibodies to prevent infection” points out Professor Keppler. The researchers developed a new virus neutralization test, which allowed them to analyze antibodies in many serum samples and different variants of the virus at high throughput rates. Professor Protzer adds: “A new finding of our study is that people require three separate exposures to the spike protein to build up high-level neutralizing activity against all viral variants, including Omicron.”

As the scientists report, various constellations are possible for these three spike encounters. Triple-vaccinated people without prior SARS-CoV-2 infection had almost the same titer and quality of neutralizing antibodies against Omicron as vaccinated convalescents or people who had a breakthrough infection with Delta or Omicron. Professor Keppler: “In all cases, the neutralization activity reached similarly high levels and this was paralleled by an increased binding strength of the antibodies.” Professor Protzer and Professor Knolle agree: “The immunity built up or strengthened by means of vaccination is key to effective protection against future variants of the virus. A recent breakthrough infection – as irritating and undesirable as it is – has in fact the same effect as an additional vaccination on this important arm of the immune system.”

Wratil, P.R., Stern, M., Priller, A. et al.
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.
Nat Med, 2022. doi: 10.1038/s41591-022-01715-4



For more Information: Sign in Websites for Agrochemical & Pharmaceutical Databases:

Website : https://www.chemrobotics.com/ (Agrochemical Databases)

Website : https://chemroboticspharma.com/  (Pharmaceutical Databases)

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Our Company

ChemRobotics is a global Scientific, Technical & Business data intelligence company, especially in the field of Pharmaceutical, Agrochemical, Veterinary and Fine Chemical.

ChemRobotics Times

Subscribe ChemRobotics for the latest updates in the Pharmaceutical, Agrochemical, Veterinary, and Fine Chemical Industries

Laest News

ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved. 

Designed and Developed by Ample eBusiness